STOCK TITAN

Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Precision Optics Corporation (NASDAQ: POCI), a specialized manufacturer of advanced optical instruments for medical and defense/aerospace sectors, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025.

The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Interested participants can access the webcast through the conference website or arrange individual meetings with management through Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI), un produttore specializzato di strumenti ottici avanzati per i settori medico e difesa/aerospaziale, ha annunciato la sua partecipazione alla prossima Conferenza per Investitori Lytham Partners Primavera 2025 che si terrà il 29 maggio 2025.

L'azienda terrà una presentazione in webcast alle 10:15 a.m. ET e organizzerà incontri individuali con gli investitori durante l'evento virtuale. I partecipanti interessati potranno seguire il webcast tramite il sito della conferenza o prenotare incontri individuali con il management tramite Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI), un fabricante especializado en instrumentos ópticos avanzados para los sectores médico y de defensa/aeroespacial, ha anunciado su participación en la próxima Conferencia de Inversores Lytham Partners Primavera 2025 que se celebrará el 29 de mayo de 2025.

La compañía realizará una presentación vía webcast a las 10:15 a.m. ET y llevará a cabo reuniones individuales con inversores durante el evento virtual. Los interesados podrán acceder al webcast a través del sitio web de la conferencia o concertar reuniones individuales con la dirección mediante Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI)는 의료 및 국방/항공우주 분야를 위한 첨단 광학 기기 전문 제조업체로, 다가오는 2025년 5월 29일에 개최되는 Lytham Partners 2025년 봄 투자자 컨퍼런스에 참가한다고 발표했습니다.

회사는 동부 표준시 오전 10시 15분에 웹캐스트 발표를 진행하며, 가상 행사 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다. 관심 있는 참가자는 컨퍼런스 웹사이트를 통해 웹캐스트에 접속하거나 Lytham Partners를 통해 경영진과 개별 미팅을 예약할 수 있습니다.

Precision Optics Corporation (NASDAQ : POCI), fabricant spécialisé d'instruments optiques avancés pour les secteurs médical et défense/aérospatial, a annoncé sa participation à la prochaine Conférence des investisseurs Lytham Partners Printemps 2025 qui se tiendra le 29 mai 2025.

L'entreprise présentera un webcast à 10h15 ET et organisera des réunions individuelles avec les investisseurs tout au long de l'événement virtuel. Les participants intéressés pourront accéder au webcast via le site de la conférence ou organiser des réunions individuelles avec la direction par l'intermédiaire de Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI), ein spezialisierter Hersteller fortschrittlicher optischer Instrumente für die Medizin- sowie Verteidigungs-/Luft- und Raumfahrtbranche, hat seine Teilnahme an der bevorstehenden Lytham Partners Frühjahrs-Investorenkonferenz 2025 am 29. Mai 2025 angekündigt.

Das Unternehmen wird um 10:15 Uhr ET eine Webcast-Präsentation halten und während der virtuellen Veranstaltung Einzelgespräche mit Investoren führen. Interessierte Teilnehmer können den Webcast über die Konferenz-Website verfolgen oder individuelle Treffen mit dem Management über Lytham Partners vereinbaren.

Positive
  • None.
Negative
  • None.

GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025.

Company Webcast
The webcast presentation will take place at 10:15 a.m. ET on Thursday, May 29, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2025/ or directly at https://app.webinar.net/3BOW97YV8R5. The webcast will also be available for replay following the event.

1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2025invreg/.

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com


FAQ

When is Precision Optics (POCI) presenting at the Lytham Partners Spring 2025 Conference?

Precision Optics (POCI) will present at 10:15 a.m. ET on Thursday, May 29, 2025.

How can investors attend POCI's presentation at the Lytham Partners Conference?

Investors can access the webcast through the conference website at lythampartners.com/spring2025/ or directly at app.webinar.net/3BOW97YV8R5.

How can investors schedule one-on-one meetings with POCI management?

Investors can arrange meetings by contacting Lytham Partners at 1x1@lythampartners.com or registering at lythampartners.com/spring2025invreg/.

What industries does Precision Optics (POCI) serve?

Precision Optics serves the medical and defense/aerospace industries as a designer and manufacturer of advanced optical instruments.
Precision Optics

NASDAQ:POCI

POCI Rankings

POCI Latest News

POCI Stock Data

33.50M
6.25M
22.44%
25.56%
0.05%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
GARDNER